More topics. More networking. More opportunities
In 2012, the 8th Annual European Antibody Congress has evolved to differentiate itself and provide the most comprehensive and focused forum for the antibody industry.
This year, we`re bringing you more specific content, more KOLs, more 1-2-1 interactions and more reasons to bring your team!
- The Monocloncal Antibody Track will focus on all things mAbs; from structure-function relationships to clinical trial advances and novel target identification
- The Antibody Drug Conjugate Track will chart the progress of ADCs in the clinic and take stock of the new payloads and linkers entering the arena
- The Bispecific and Alternative Proteins Track will explore the multitude of possibilities surrounding bispecific antibodies and alternative scaffolds
DOWNLOAD the brochure today to make sure you're in the know!